Martin Leverkus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Martin Leverkus has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Peter Geserick
Laboratory of Experimental Dermatology, Department of Dermatology and Venerology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
4 shared publicationsAxel Trautmann
Laboratory for Experimental Dermatology, Department of Dermatology and Venerology, Otto von Guericke University of Magdeburg, Magdeburg, Germany
2 shared publicationsHarald Gollnick
Laboratory for Experimental Dermatology, Department of Dermatology and Venereology, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany 1
2 shared publications- John Silke
The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
2 shared publications - Mike Hupe
Ludwig Institute for Cancer Research Ltd., Box 240, Stockholm SE-171 77, Sweden.
2 shared publications Philip Diessenbacher
Laboratory for Experimental Dermatology, Department of Dermatology and Venerology, Otto‐von‐Guericke‐University Magdeburg, Magdeburg, Germany
2 shared publications
Latest Publications
- Open Access
- 1 June 2010
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (6b) , 1760-1776
The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL‐mediated apoptosis
Primary endothelial cells are fully resistant to TNF‐related apoptosis‐inducing ligand (TRAIL)‐mediated apoptosis. Here, we demonstrate that certain environmental conditions, such as exposure to the widespread allergen nickel, can dramatically increase the susceptibility of naturally resistant primary endothelial cells or keratinocytes to TRAIL‐induced apoptosis. While nickel treatment increased surface expression of the apoptosis‐inducing TRAIL receptors TRAIL‐R1 and TRAIL‐R2, it also up‐regulated the apoptosis‐deficient TRAIL‐R4, suggesting that modulation of TRAIL receptor expression alone is unlikely to fully account for the dramatic sensitization effect of nickel. Further analysis of candidate mediators revealed that nickel strongly repressed c‐FLIP at mRNA and protein levels. Accordingly, increased activation of Caspase‐8 and Caspase‐3 following nickel treatment was observed. Importantly, depletion of c‐FLIP by RNA interference could largely recapitulate the effect of nickel and sensitize endothelial cells to TRAIL‐dependent apoptosis in the absence of nickel pre‐treatment. Conversely, ectopic expression of c‐FLIPL largely protected nickel‐treated cells from TRAIL‐mediated apoptosis. Our data demonstrate that one key mechanism of sensitization of primary human endothelial cells or keratinocytes is transcriptional down‐regulation of c‐FLIP. We hypothesize that environmental factors, exemplified by the contact allergen nickel, strongly modulate death ligand sensitivity of endothelial cells and keratinocytes thus influencing vascular and epidermal function and integrity under physiological and pathophysiological conditions.
- 1 June 2010
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (6b) , 1760-1776
Open AccessThe contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL‐mediated apoptosis
Primary endothelial cells are fully resistant to TNF‐related apoptosis‐inducing ligand (TRAIL)‐mediated apoptosis. Here, we demonstrate that certain environmental conditions, such as exposure to the widespread allergen nickel, can dramatically increase the susceptibility of naturally resistant primary endothelial cells or keratinocytes to TRAIL‐induced apoptosis. While nickel treatment increased surface expression of the apoptosis‐inducing TRAIL receptors TRAIL‐R1 and TRAIL‐R2, it also up‐regulated the apoptosis‐deficient TRAIL‐R4, suggesting that modulation of TRAIL receptor expression alone is unlikely to fully account for the dramatic sensitization effect of nickel. Further analysis of candidate mediators revealed that nickel strongly repressed c‐FLIP at mRNA and protein levels. Accordingly, increased activation of Caspase‐8 and Caspase‐3 following nickel treatment was observed. Importantly, depletion of c‐FLIP by RNA interference could largely recapitulate the effect of nickel and sensitize endothelial cells to TRAIL‐dependent apoptosis in the absence of nickel pre‐treatment. Conversely, ectopic expression of c‐FLIPL largely protected nickel‐treated cells from TRAIL‐mediated apoptosis. Our data demonstrate that one key mechanism of sensitization of primary human endothelial cells or keratinocytes is transcriptional down‐regulation of c‐FLIP. We hypothesize that environmental factors, exemplified by the contact allergen nickel, strongly modulate death ligand sensitivity of endothelial cells and keratinocytes thus influencing vascular and epidermal function and integrity under physiological and pathophysiological conditions.
- Open Access
- 28 December 2009
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 187 (7) , 1037-1054
Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
A role for cellular inhibitors of apoptosis (IAPs [cIAPs]) in preventing CD95 death has been suspected but not previously explained mechanistically. In this study, we find that the loss of cIAPs leads to a dramatic sensitization to CD95 ligand (CD95L) killing. Surprisingly, this form of cell death can only be blocked by a combination of RIP1 (receptor-interacting protein 1) kinase and caspase inhibitors. Consistently, we detect a large increase in RIP1 levels in the CD95 death-inducing signaling complex (DISC) and in a secondary cytoplasmic complex (complex II) in the presence of IAP antagonists and loss of RIP1-protected cells from CD95L/IAP antagonist–induced death. Cells resistant to CD95L/IAP antagonist treatment could be sensitized by short hairpin RNA–mediated knockdown of cellular FLICE-inhibitory protein (cFLIP). However, only cFLIPL and not cFLIPS interfered with RIP1 recruitment to the DISC and complex II and protected cells from death. These results demonstrate a fundamental role for RIP1 in CD95 signaling and provide support for a physiological role of caspase-independent death receptor–mediated cell death.
- 28 December 2009
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 187 (7) , 1037-1054
Open AccessCellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
A role for cellular inhibitors of apoptosis (IAPs [cIAPs]) in preventing CD95 death has been suspected but not previously explained mechanistically. In this study, we find that the loss of cIAPs leads to a dramatic sensitization to CD95 ligand (CD95L) killing. Surprisingly, this form of cell death can only be blocked by a combination of RIP1 (receptor-interacting protein 1) kinase and caspase inhibitors. Consistently, we detect a large increase in RIP1 levels in the CD95 death-inducing signaling complex (DISC) and in a secondary cytoplasmic complex (complex II) in the presence of IAP antagonists and loss of RIP1-protected cells from CD95L/IAP antagonist–induced death. Cells resistant to CD95L/IAP antagonist treatment could be sensitized by short hairpin RNA–mediated knockdown of cellular FLICE-inhibitory protein (cFLIP). However, only cFLIPL and not cFLIPS interfered with RIP1 recruitment to the DISC and complex II and protected cells from death. These results demonstrate a fundamental role for RIP1 in CD95 signaling and provide support for a physiological role of caspase-independent death receptor–mediated cell death.
- Open Access
- 3 June 2008
- Published by Wiley in Experimental Dermatology
- Vol. 17 (7) , 614-622
FLIP ing the coin? Death receptor‐mediated signals during skin tumorigenesis
Abstract: Keratinocyte skin cancer is a multi‐step process, during which a number of obstacles have to be overcome by the tumor cell to allow the development of a manifest tumor. Beside proliferation and immortality, apoptosis resistance is one additional and critical step during skin carcinogenesis. Over the past two decades, much has been learned about the prototypical membrane‐bound inducers of apoptosis, namely the death receptors and their ligands, and the apoptosis signalling pathways activated by death receptors have been elucidated in great detail. In contrast, much less is known about the tissue‐specific role of the death receptor/ligands systems during the development of skin cancer. Here, we summarize and discuss the role of this intriguing receptor family and the potential mechanistical impact of the intracellular caspase‐8 inhibitor cFLIP for keratinocyte skin cancer. Given more recent data about cFLIP and its isoforms, a more complex regulatory role of cFLIP can be suspected. Indeed, cFLIP may not solely interfere with death receptor‐mediated apoptosis signalling pathways, but may positively or negatively influence other, potential harmful signalling pathways such as the production of inflammatory cytokines, tumor cell migration or the activation of transcription factors such as NF‐κB, considered crucial during skin tumorigenesis. In this respect, cFLIP may act to ‘FLIP the coin’ during the development of keratinocyte skin cancer.
- 3 June 2008
- Published by Wiley in Experimental Dermatology
- Vol. 17 (7) , 614-622
Open AccessFLIP ing the coin? Death receptor‐mediated signals during skin tumorigenesis
Abstract: Keratinocyte skin cancer is a multi‐step process, during which a number of obstacles have to be overcome by the tumor cell to allow the development of a manifest tumor. Beside proliferation and immortality, apoptosis resistance is one additional and critical step during skin carcinogenesis. Over the past two decades, much has been learned about the prototypical membrane‐bound inducers of apoptosis, namely the death receptors and their ligands, and the apoptosis signalling pathways activated by death receptors have been elucidated in great detail. In contrast, much less is known about the tissue‐specific role of the death receptor/ligands systems during the development of skin cancer. Here, we summarize and discuss the role of this intriguing receptor family and the potential mechanistical impact of the intracellular caspase‐8 inhibitor cFLIP for keratinocyte skin cancer. Given more recent data about cFLIP and its isoforms, a more complex regulatory role of cFLIP can be suspected. Indeed, cFLIP may not solely interfere with death receptor‐mediated apoptosis signalling pathways, but may positively or negatively influence other, potential harmful signalling pathways such as the production of inflammatory cytokines, tumor cell migration or the activation of transcription factors such as NF‐κB, considered crucial during skin tumorigenesis. In this respect, cFLIP may act to ‘FLIP the coin’ during the development of keratinocyte skin cancer.
- 1 May 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (5) , 1134-1147
NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2
- 1 May 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (5) , 1134-1147
NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2
- 1 November 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (11) , 2364-2366
CD95-Mediated Signals in the Skin: Going Out with an (Inflammatory) Bang?
- 1 November 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (11) , 2364-2366
CD95-Mediated Signals in the Skin: Going Out with an (Inflammatory) Bang?
- 1 June 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (6) , 1212-1214
“Bak (and Bax) to the Future” — of Primary Melanoma Prognosis?
- 1 June 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (6) , 1212-1214
“Bak (and Bax) to the Future” — of Primary Melanoma Prognosis?
- 1 January 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (1) , 91-96
Bullous Allergic Hypersensitivity to Bed Bug Bites Mediated by IgE against Salivary Nitrophorin
- 1 January 2006
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (1) , 91-96
Bullous Allergic Hypersensitivity to Bed Bug Bites Mediated by IgE against Salivary Nitrophorin